No Data
Express News | Stand up to Cancer Collaborates With Johnson & Johnson to Explore Targeted Therapies for Rare Disease Linked to Blood Cancers
STAND UP TO CANCER COLLABORATES WITH JOHNSON & JOHNSON TO EXPLORE TARGETED THERAPIES FOR RARE DISEASE LINKED TO BLOOD CANCERS
Johnson & Johnson's (NYSE:JNJ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With Johnson & Johnson (NYSE:JNJ) It Looks Like You'll Get What You Pay For
Express News | Johnson & Johnson Submits Applications in the U.S. and EU Seeking Approval of Darzalex Faspro® / Darzalex® as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Express News | shanghai Municipal Medical Insurance Bureau organizes centralized procurement of pharmaceuticals and high-value consumables exceeding 2 billion yuan